CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Mark Wallace

OPENALEX: A5101705774↗OPENALEX: A5103590083↗ORCID: 0000-0001-5647-6233↗

Affiliations

Organizations

Apple (Israel)authorship · IL Center Pointauthorship · US Gobierno de Canariasauthorship · ES Pain and Rehabilitation Medicineauthorship · US UC San Diego Health Systemauthorship · US University of California San Diegoauthorship · US University of California San Diego Medical Centerauthorship · US University of California, San Franciscoauthorship · US University of Leedsauthorship · GB

Public evidence

4 connected articles

Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trial.2026 · Europe PMC Medical cannabis authorization and opioid milligram equivalents over time in patients with chronic pain: a retrospective analysis.2026 · PubMed Central Open Access Cannabinoids, cannabis, and cannabis-based medicine for pain management: a protocol for an overview of systematic reviews and a systematic review of randomised controlled trials.2019 · Europe PMC A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain.2019 · PubMed Central Open Access

Registered research

Connected studies

Efficacy of Inhaled Cannabis Versus Placebo for the Acute Treatment of Migraine: a Randomized, Double-blind, Placebo-controlled, Crossover Trialnct04360044

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Mark Wallace - Medical Cannabis Research Engine